United Kingdom · Biotechnology startup
United Kingdom · Capella BioScience
Capella Bioscience engages in the discovery and development of monoclonal antibodies.
Funding reportedLast round: Series A
What company datasets say Capella BioScience raised
Funding, as reported
Reported in all15.5Min the source's currency
Rounds2
Last roundSeries A
Last round dateMar 2016
Investors listed5
Biotechnology in United Kingdom
Startups like it
F2GManchester · founded 1998
COMPASS PathwaysAltrincham · founded 2016- IdrxLondon · founded 2022
PepgenOxford · founded 2018
Beckley PsytechBeckley · founded 2019
Cambridge EpigenetixChesterford Research Park · founded 2012
Ascend Gene And Cell Therapies Ltd.Altrincham · founded 2021
Green BiologicsAbingdon · founded 2003
Is this your company?
Add your raise, your deck and your story, and put Capella BioScience in front of investors. Or tell us what we have wrong.